Glenn A. Miller
Direktor/Vorstandsmitglied bei BioMarker Strategies LLC
Aktive Positionen von Glenn A. Miller
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BioMarker Strategies LLC
BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology BioMarker Strategies LLC develops medicines for cancer. It provides cancer diagnostics system for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. The company was founded by Scott Allocco, Kathleen Murphy and Douglas P. Clark in May 2006 and is headquartered in Rockville, MD. | Direktor/Vorstandsmitglied | 31.05.2011 | - |
Vorsitzender | 07.10.2011 | 04.10.2012 | |
The Human Genome Organization | Corporate Officer/Principal | - | - |
Karriereverlauf von Glenn A. Miller
Ehemalige bekannte Positionen von Glenn A. Miller
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MolecularMD Corp.
MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Technik-/Wissenschafts-/F&E-Leiter | 08.08.2013 | - |
Genzyme Analytical Services | Corporate Officer/Principal | - | - |
ASTRAZENECA PLC | Corporate Officer/Principal | 31.05.2011 | - |
Ausbildung von Glenn A. Miller
The State University of New York | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Vereinigtes Königreich | 3 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Chairman | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ASTRAZENECA PLC | Health Technology |
Private Unternehmen | 4 |
---|---|
BioMarker Strategies LLC
BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology BioMarker Strategies LLC develops medicines for cancer. It provides cancer diagnostics system for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. The company was founded by Scott Allocco, Kathleen Murphy and Douglas P. Clark in May 2006 and is headquartered in Rockville, MD. | Health Technology |
MolecularMD Corp.
MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Health Services |
Genzyme Analytical Services | |
The Human Genome Organization |
- Börse
- Insiders
- Glenn A. Miller
- Erfahrung